Embecta Corp. (EMBC)
USD 11.9
(-3.25%)
USD 11.9
(-3.25%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.12 Billion USD | -0.77% |
| 2022 | 1.12 Billion USD | -3.05% |
| 2021 | 1.16 Billion USD | 7.32% |
| 2020 | 1.08 Billion USD | -2.12% |
| 2019 | 1.1 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 272.5 Million USD | -5.12% |
| 2024 Q1 | 277.3 Million USD | -1.63% |
| 2024 Q2 | 287.2 Million USD | 3.57% |
| 2023 Q4 | 281.9 Million USD | -1.47% |
| 2023 FY | 1.12 Billion USD | -0.77% |
| 2023 Q3 | 286.1 Million USD | 3.25% |
| 2023 Q2 | 277.1 Million USD | 0.51% |
| 2023 Q1 | 275.7 Million USD | 0.4% |
| 2022 Q1 | 289.3 Million USD | -3.73% |
| 2022 FY | 1.12 Billion USD | -3.05% |
| 2022 Q4 | 274.6 Million USD | -5.67% |
| 2022 Q3 | 291.1 Million USD | 6.05% |
| 2022 Q2 | 274.5 Million USD | -5.12% |
| 2021 Q1 | 285.3 Million USD | 0.0% |
| 2021 Q4 | 300.5 Million USD | 1.86% |
| 2021 Q3 | 295 Million USD | 3.8% |
| 2021 FY | 1.16 Billion USD | 7.32% |
| 2021 Q2 | 284.2 Million USD | -0.39% |
| 2020 FY | 1.08 Billion USD | -2.12% |
| 2019 FY | 1.1 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | -97.753% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | -130.231% |
| Dynavax Technologies Corporation | 232.28 Million USD | -382.513% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | -863.433% |
| Pacira BioSciences, Inc. | 674.97 Million USD | -66.05% |
| PainReform Ltd. | - USD | -Infinity% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | -2115.764% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -4552.015% |
| SCYNEXIS, Inc. | 140.14 Million USD | -699.766% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -58017.798% |
| Cosmos Health Inc. | 53.37 Million USD | -1999.786% |
| Journey Medical Corporation | 79.18 Million USD | -1315.491% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -4552.015% |
| Safety Shot Inc | 202.67 Thousand USD | -552917.22% |
| Alpha Teknova, Inc. | 36.68 Million USD | -2955.283% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | -141.359% |
| Bright Green Corporation | 401.49 Thousand USD | -279059.433% |
| Procaps Group, S.A. | 409.92 Million USD | -173.419% |
| Theratechnologies Inc. | 81.76 Million USD | -1270.774% |
| Harrow Health, Inc. | 130.19 Million USD | -760.876% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -8700.942% |
| Biofrontera Inc. | 34.07 Million USD | -3189.601% |
| DURECT Corporation | 8.54 Million USD | -13011.839% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | -84.487% |
| Cronos Group Inc. | 88.84 Million USD | -1161.581% |
| OptiNose, Inc. | 70.98 Million USD | -1478.881% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | -153.154% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -17108.203% |
| Organogenesis Holdings Inc. | 433.14 Million USD | -158.762% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -9050.471% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | -2733.702% |
| Radius Health, Inc. | 2.88 Billion USD | 61.113% |
| Universe Pharmaceuticals INC | 32.3 Million USD | -3369.031% |
| ProPhase Labs, Inc. | 44.38 Million USD | -2425.234% |
| Phibro Animal Health Corporation | 1.01 Billion USD | -10.133% |
| Procaps Group S.A. | 409.92 Million USD | -173.419% |
| Alvotech | 91.43 Million USD | -1125.802% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -85982.949% |
| Viatris Inc. | 15.42 Billion USD | 92.735% |
| Rockwell Medical, Inc. | 83.61 Million USD | -1240.477% |
| Aytu BioPharma, Inc. | 81 Million USD | -1283.67% |
| SIGA Technologies, Inc. | 139.91 Million USD | -701.045% |
| Tilray Brands, Inc. | 788.94 Million USD | -42.064% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | -773.843% |
| Shineco, Inc. | 9.8 Million USD | -11334.569% |
| PetIQ, Inc. | 1.1 Billion USD | -1.709% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 12 Thousand USD | -9339900.0% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 40.607% |
| Alimera Sciences, Inc. | 80.75 Million USD | -1287.919% |
| Silver Spike Investment Corp. | 11.72 Million USD | -9461.4% |
| Assertio Holdings, Inc. | 152.06 Million USD | -637.034% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -19149.834% |
| Clever Leaves Holdings Inc. | 17.41 Million USD | -6335.092% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -104024.377% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -3908.154% |
| Hempacco Co., Inc. | 4.04 Million USD | -27603.919% |
| Talphera, Inc. | 651 Thousand USD | -172065.899% |
| Alvotech | 91.43 Million USD | -1125.802% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | -254.0% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | 13.547% |
| Currenc Group, Inc. | 53.25 Million USD | -2004.577% |
| Kamada Ltd. | 144.75 Million USD | -674.254% |
| Indivior PLC | 1.09 Billion USD | -2.543% |
| Evoke Pharma, Inc. | 5.18 Million USD | -21534.434% |
| Flora Growth Corp. | 76.07 Million USD | -1373.36% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -104024.377% |
| Evolus, Inc. | 202.08 Million USD | -454.618% |
| HUTCHMED (China) Limited | 837.99 Million USD | -33.747% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | -73.931% |
| Akanda Corp. | 2.16 Million USD | -51787.64% |